CAJ | 학술논문

战略性新兴产业是国民经济的主导产业，将成为中国经济新的增长引擎，但融资难一直困扰着战略性新兴产业成果的顺利转化。专利质押融资作为现代金融和高科技结合的产物，能有效弥补传统融资方式的局限。本文把战略性新兴产业——生物医药产业作为研究对象，通过构建生物医药专利质押融资绩效评价指标体系，评价生物医药行业专利质押融资现状，探讨其存在的问题以及政策成因，为完善我国专利质押融资制度提出建议。
전략성신흥산업시국민경제적주도산업，장성위중국경제신적증장인경，단융자난일직곤우착전략성신흥산업성과적순리전화。전리질압융자작위현대금융화고과기결합적산물，능유효미보전통융자방식적국한。본문파전략성신흥산업——생물의약산업작위연구대상，통과구건생물의약전리질압융자적효평개지표체계，평개생물의약행업전리질압융자현상，탐토기존재적문제이급정책성인，위완선아국전리질압융자제도제출건의。
Strategic emerging industry, the dominant industry of national economy, will become the new engine of China＇s economy growth, while its achievement of successful transformation is always impeded by the issue of financing. As the combined product of mod- ern finance and high-technology, patent pledge could effectively relieve the funds scarcity. Through constructing a performance evalua- tion system, this paper aimed to review the current situation of patent pledge in bio-medical industry and probe on its existing problems and causes, thereby providing suggestions for the improvement of patent pledge in China.